Universitätsklinikum Frankfurt am Main (KGU)

Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial (2015) Bader P, Kreyenberg H, Von Stackelberg A, Eckert C, Salzmann-Manrique E, Meisel R, Poetschger U, et al. Journal article Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial (2015) Schetelig J, Schaich M, Schaefer-Eckart K, Haenel M, Aulitzky WE, Einsele H, Schmitz N, et al. Journal article Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015) (2015) Denschlag D, Thiel FC, Ackermann S, Harter P, Juhasz-Boess I, Mallmann P, Strauss HG, et al. Journal article A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis (2015) Buch S, Stickel F, Trepo E, Way M, Herrmann A, Nischalke HD, Brosch M, et al. Journal article Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015) (2015) Untch M, Harbeck N, Huober J, Von Minckwitz G, Gerber B, Kreipe HH, Liedtke C, et al. Journal article, Review article Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients (2015) Hecht M, Zimmer L, Loquai C, Weishaupt C, Gutzmer R, Schuster B, Gleisner S, et al. Journal article Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer : Results of the first prospective randomized phase II trial (2015) Golcher H, Brunner T, Witzigmann H, Marti L, Bechstein WO, Bruns C, Jungnickel H, et al. Journal article What opportunities does Immuno-oncology indicate for overarching long-term survival? (2015) Bergmann L, Brugger W, Herr W, Mackensen A, Multhoff G Journal article Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial (2015) Rollig C, Serve H, Huettmann A, Noppeney R, Mueller-Tidow C, Krug U, Baldus CD, et al. Journal article Allogeneic Stem-Cell Transplantation in Patients With NPM1-Mutated Acute Myeloid Leukemia: Results From a Prospective Donor Versus No-Donor Analysis of Patients After Upfront HLA Typing Within the SAL-AML 2003 Trial (2015) Roellig C, Bornhaeuser M, Kramer M, Thiede C, Ho AD, Kraemer A, Schaefer-Eckart K, et al. Journal article